Evidence map›Paper›PMID 23740243›Full record

ArticleThe Journal of biological chemistry2013

Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration.

Ikuo Nakamura, Maite G Fernandez-Barrena, Maria C Ortiz-Ruiz, Luciana L Almada, Chunling Hu, Sherine F Elsawa, Lisa D Mills, Paola A Romecin, Kadra H Gulaid, Catherine D Moser and 10 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Ikuo NakamuraFrom the Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905.
Maite G Fernandez-Barrenathe Schulze Center for Novel Therapeutics and.
Maria C Ortiz-Ruizthe Departamento de Fisiología Facultad de Medicina Universidad de Murcia, 30100 Murcia, Spain.
Luciana L Almadathe Schulze Center for Novel Therapeutics and.
Chunling HuFrom the Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905.
Sherine F Elsawathe Department of Biological Sciences, Northern Illinois University, Illinois 60115.
Lisa D Millsthe Schulze Center for Novel Therapeutics and.
Paola A Romecinthe Departamento de Fisiología Facultad de Medicina Universidad de Murcia, 30100 Murcia, Spain.
Kadra H GulaidFrom the Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905.
Catherine D MoserFrom the Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905.
Jing-Jing Hanthe Schulze Center for Novel Therapeutics and.
Anne Vrabelthe Schulze Center for Novel Therapeutics and.
Eric A Hansethe Division of Gastroenterology, Hennepin County Medical Center, Minneapolis, Minnesota 55404.
Nicholas A AkogyeramFrom the Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905.
Jeffrey H Albrechtthe Division of Gastroenterology, Hennepin County Medical Center, Minneapolis, Minnesota 55404.
Satdarshan P S Mongathe Departments of Pathology and Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15216, and.
Schuyler O SandersonDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905.
Jesus Prietothe Centro de Investigacion Medica Aplicada, 31008 Pamplona, Spain.
Lewis R RobertsFrom the Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905,. Electronic address: roberts.lewis@mayo.edu.
Martin E Fernandez-ZapicoFrom the Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Clinic Cancer Center, Rochester, Minnesota 55905,; the Schulze Center for Novel Therapeutics and. Electronic address: fernandezzapico.martin@mayo.edu.
Novel (United States) · USWinnMed · USMayo Clinic · USHennepin County Medical Center · USUniversidad de Murcia · ESNorthern Illinois University · USUniversity of Pittsburgh · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Mayo Clinic Center for Translational Science ActivitiesKL2RR024151 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$15.3M
The Cyclin D1/CDK4 Complex in Hepatocyte ProliferationR01DK054921 · NIDDK · UNIVERSITY OF MINNESOTA · PI ALBRECHT, JEFFREY H · 1998 to 2017
$4.5M
Mechanism of Pancreatic CarcinogenesisR01CA136526 · NCI · MAYO CLINIC ROCHESTER · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO · 2009 to 2019
$3.0M
Regulation of the Tumor Microenvironment in Hepatocellular CarcinomaR01CA165076 · NCI · MAYO CLINIC ROCHESTER · PI FERNANDEZ-ZAPICO, MARTIN ERNESTO, ROBERTS, LEWIS R · 2012 to 2016
$2.0M
Molecular Pathogenesis of Hepatocellular CarcinomaR01CA100882 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2004 to 2008
$1.8M
Dysregulation of the Tumor Microenvironment in Hepatocellular CarcinomaR21CA128633 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2009 to 2010
$366k
Molecular Pathogenesis of Hepatocellular CarcinomaR56CA100882 · NCI · MAYO CLINIC ROCHESTER · PI ROBERTS, LEWIS R · 2009 to 2009
$352k
NCI NIH HHS CA100882NCI NIH HHS CA128633NCI NIH HHS CA165076NCI NIH HHS N01 CA015083NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA100882NCI NIH HHS R01 CA136526NCI NIH HHS R01 CA165076NCI NIH HHS R21 CA128633NCI NIH HHS R56 CA100882NCRR NIH HHS KL2 RR024151NIDDK NIH HHS P30 DK084567NIDDK NIH HHS P30DK084567NIDDK NIH HHS R01 DK054921
6 · The paper itself

Abstract

Tissue regeneration requires the activation of a set of specific growth signaling pathways. The identity of these cascades and their biological roles are known; however, the molecular mechanisms regulating the interplay between these pathways remain poorly understood. Here, we define a new role for SULFATASE 2 (SULF2) in regulating tissue regeneration and define the WNT-GLI1 axis as a novel downstream effector for this sulfatase in a liver model of tissue regeneration. SULF2 is a heparan sulfate 6-O-endosulfatase, which releases growth factors from extracellular storage sites turning active multiple signaling pathways. We demonstrate that SULF2-KO mice display delayed regeneration after partial hepatectomy (PH). Mechanistic analysis of the SULF2-KO phenotype showed a decrease in WNT signaling pathway activity in vivo. In isolated hepatocytes, SULF2 deficiency blocked WNT-induced β-CATENIN nuclear translocation, TCF activation, and proliferation. Furthermore, we identified the transcription factor GLI1 as a novel target of the SULF2-WNT cascade. WNT induces GLI1 expression in a SULF2- and β-CATENIN-dependent manner. GLI1-KO mice phenocopied the SULF2-KO, showing delayed regeneration and decreased hepatocyte proliferation. Moreover, we identified CYCLIN D1, a key mediator of cell growth during tissue regeneration, as a GLI1 transcriptional target. GLI1 binds to the cyclin d1 promoter and regulates its activity and expression. Finally, restoring GLI1 expression in the liver of SULF2-KO mice after PH rescues CYCLIN D1 expression and hepatocyte proliferation to wild-type levels. Thus, together these findings define a novel pathway in which SULF2 regulates tissue regeneration in part via the activation of a novel WNT-GLI1-CYCLIN D1 pathway.

Indexed as

Liver RegenerationWnt Signaling PathwayAnimalsbeta CateninCell ProliferationDown-RegulationHedgehog ProteinsHepatectomyHepatocytesKruppel-Like Transcription FactorsMiceMice, Inbred C57BLModels, BiologicalSulfatasesWnt3A ProteinZinc Finger Protein GLI1beta CateninGli1 protein, mouseHedgehog ProteinsKruppel-Like Transcription FactorsSulf2 protein, mouseSulfatasesWnt3A ProteinZinc Finger Protein GLI1Gene KnockoutLiverRegenerationTranscription FactorsWnt Signaling

Identifiers

PMID23740243
PMCPMC3774406
OpenAlexW2063260672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.